RBC Analyst Questions Chemring’s Ability to Meet FY2026 Guidance
RBC Capital Markets’ Ben Pfannes-Varrow says Chemring may struggle to meet fiscal 2026 guidance despite a deal worth at least $170 million over its first five years. The company has about two weeks left in its financial year.